Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms.
Mapelli P, Partelli S, Salgarello M, Doraku J, Muffatti F, Schiavo Lena M, Pasetto S, Bezzi C, Bettinardi V, Andreasi V, Rancoita PMV, Gianolli L, Picchio M, Falconi M. Mapelli P, et al. Among authors: bezzi c. Diagnostics (Basel). 2021 Jan 28;11(2):192. doi: 10.3390/diagnostics11020192. Diagnostics (Basel). 2021. PMID: 33525712 Free PMC article.
Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients.
Mapelli P, Ghezzo S, Samanes Gajate AM, Preza E, Brembilla G, Cucchiara V, Ahmed N, Bezzi C, Presotto L, Bettinardi V, Savi A, Magnani P, Menichini R, Coliva A, Neri I, Di Gaeta E, Gianolli L, Freschi M, Briganti A, De Cobelli F, Scifo P, Picchio M. Mapelli P, et al. Among authors: bezzi c. Diagnostics (Basel). 2021 Nov 9;11(11):2068. doi: 10.3390/diagnostics11112068. Diagnostics (Basel). 2021. PMID: 34829417 Free PMC article.
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data.
Mapelli P, Ghezzo S, Samanes Gajate AM, Preza E, Palmisano A, Cucchiara V, Brembilla G, Bezzi C, Rigamonti R, Magnani P, Toninelli E, Bettinardi V, Suardi N, Gianolli L, Scifo P, Briganti A, De Cobelli F, Esposito A, Picchio M. Mapelli P, et al. Among authors: bezzi c. Cancers (Basel). 2022 Jan 11;14(2):334. doi: 10.3390/cancers14020334. Cancers (Basel). 2022. PMID: 35053499 Free PMC article.
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort.
Ironi G, Mapelli P, Bergamini A, Fallanca F, Candotti G, Gnasso C, Taccagni GL, Sant'Angelo M, Scifo P, Bezzi C, Bettinardi V, Rancoita PMV, Mangili G, Bocciolone L, Candiani M, Gianolli L, De Cobelli F, Picchio M. Ironi G, et al. Among authors: bezzi c. Clin Nucl Med. 2022 Mar 1;47(3):e221-e229. doi: 10.1097/RLU.0000000000004064. Clin Nucl Med. 2022. PMID: 35067539
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours.
Mapelli P, Bezzi C, Palumbo D, Canevari C, Ghezzo S, Samanes Gajate AM, Catalfamo B, Messina A, Presotto L, Guarnaccia A, Bettinardi V, Muffatti F, Andreasi V, Schiavo Lena M, Gianolli L, Partelli S, Falconi M, Scifo P, De Cobelli F, Picchio M. Mapelli P, et al. Among authors: bezzi c. Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2352-2363. doi: 10.1007/s00259-022-05677-0. Epub 2022 Feb 14. Eur J Nucl Med Mol Imaging. 2022. PMID: 35156146
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease.
Bezzi C, Monaco L, Ghezzo S, Mathoux G, Bergamini A, Zambella E, Fallanca F, Samanes Gajate AM, Presotto L, Sabetta G, Mangili G, Cioffi R, Bettinardi V, Gianolli L, Mapelli P, Picchio M. Bezzi C, et al. Clin Nucl Med. 2022 Jun 1;47(6):525-531. doi: 10.1097/RLU.0000000000004135. Epub 2022 Mar 30. Clin Nucl Med. 2022. PMID: 35353763
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness.
Bezzi C, Bergamini A, Mathoux G, Ghezzo S, Monaco L, Candotti G, Fallanca F, Gajate AMS, Rabaiotti E, Cioffi R, Bocciolone L, Gianolli L, Taccagni G, Candiani M, Mangili G, Mapelli P, Picchio M. Bezzi C, et al. Cancers (Basel). 2023 Jan 3;15(1):325. doi: 10.3390/cancers15010325. Cancers (Basel). 2023. PMID: 36612321 Free PMC article.
31 results